G1 Therapeutics’ approach to cancer does not kill tumors. Instead, the biotech’s drug, trilaciclib, protects bone marrow from the damaging effects of chemotherapy, reducing the duration and severity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback